Self-management of Post COVID-19 Syndrome Using Wearable Biometric Technology
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Change in lung capacity
研究概览
简要总结
The main objective of this pilot study is to evaluate the impact of a self-management intervention using wearable biometric technology on post-COVID-19 syndrome. In addition, this pilot-study will provide information regarding validity, feasibility, patient compliance and satisfaction, valuable for the design of a future large-scale study.
详细描述
This pilot-study uses a one-group before-after design. Subjects: a convenience sample of 20 adults 18 years and older in the Winnipeg Health Region with a post-COVID-19 infection (≥ 3 months since acute infection) complaining of mild to severe persistent respiratory symptoms. Intervention: using the participants' initial assessment, personal characteristics, main complaints/needs and goals, the therapist will adjust the exercise plan and personalize the recommendations (e.g. maximum heart rate) as well as instruct the patients about safety precautions (how to pace themselves, when to seek professional or emergency care). Participants will be encouraged to wear the smart shirt as much as they want during the 6 weeks (29), but at a minimum of 1-hour a day (M-F) including while performing the recommended exercises (30-45 min/3 times a week). They should self-monitor their biometric values trying to reach/stay within the target values while wearing the shirt using Hexoskin app installed on an iPad provided by the research team or on the participants' personal device if preferred. Patients will also complete an online survey reporting symptoms intensity and activities completed, 3 times a week (over 6 weeks). Participants would be able to contact the research assistant overseeing the intervention at any time of the study if they have questions or concerns (text message or email). Otherwise, they will receive a follow-up phone call every week or if a significant change in their biometrical data is identified.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Post-COVID-19 ≥ 3 months after infection.
- •Mild to severe persistent respiratory symptoms
- •Access to a home internet
排除标准
- •History of neurological disease or mental illness
- •Inability to ambulate independently without supervision
- •Inability to complete basic tasks on a smart phone or tablet
结局指标
主要结局
Change in lung capacity
时间窗: 6 weeks
It will be assessed using a SpiroBank Smart F/V multi parameter spirometer (MIR) at pre-post intervention and once a week in between to monitor changes. This portable spirometer, which is MDSAP approved and complaint with ATS/ERS guidelines, connects automatically via Bluetooth to an iOS \& Android compatible App (MIR Spirobank). It provides real time feedback through messages and animation on smartphone, to improve personal compliance during the test. The app can generate test results PDF printout with information regarding 19 parameters of lung capacity.
Change in dyspnea
时间窗: 6 weeks
Modified Borg Scale (0 "best" to 10 "worse dyspnea") will be used to assess dyspnea.
Change in fatigue
时间窗: 6 weeks
Fatigue severity scale (0 -7 "more fatigue") will be used to measure the severity of fatigue.
Chronic fatigue syndrome
时间窗: 6 weeks
DePaul Symptoms Questionnaire short form (DSQ-SF) (0 "not present" - 4 "very severe")
Health-related quality of life
时间窗: 6 weeks
EuroQol five-dimensional questionnaire (0 "worse health" to 100 "best health")
Postural orthostatic hypotension
时间窗: 6 weeks
Orthostatic Stress Test (Postural transitions)
Exercise capacity
时间窗: 6 weeks
The 6-min walk test (6 MWT) and the one-minute sit-to-stand test
次要结局
- Symptoms change(6 weeks)
- Patient satisfaction with the study(6 week)
研究者
Diana C Sanchez-Ramirez, PhD
Assistant professor
University of Manitoba
